InvestSMART

Paradigm Biopharmaceuticals Limited (ASX: PAR) - Announcements

- Current share price for PAR : $0.180

ASX company news and announcements for Paradigm Biopharmaceuticals Limited (PAR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Paradigm Biopharmaceuticals Limited (PAR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Paradigm Biopharmaceuticals Limited (PAR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Paradigm Biopharmaceuticals Limited (PAR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$108 Application for quotation of securities - PAR 30 Jul 2026 4:56PM $0.160 $0.180 risen by 12.50%
$108 June 2026 Quarterly Activities Report & Appendix 4C 30 Jul 2026 9:55AM $0.165 $0.180 risen by 9.09%
$108 Notification of cessation of securities - PAR 27 Jul 2026 8:17AM $0.165 $0.180 risen by 9.09%
$108 Paradigm Receives $5.75m R&D Tax Incentive Refund 22 Jul 2026 8:18AM $0.165 $0.180 risen by 9.09%
$108 Application for quotation of securities - PAR 17 Jul 2026 6:51PM $0.170 $0.180 risen by 5.88%
$108 Notice under Section 708A 13 Jul 2026 1:32PM $0.175 $0.180 risen by 2.86%
$108 Notification regarding unquoted securities - PAR 13 Jul 2026 1:21PM $0.175 $0.180 risen by 2.86%
$108 Drawdown of Tranche 4 under the Convertible Note Facility 13 Jul 2026 1:14PM $0.175 $0.180 risen by 2.86%
$108 Change of Director's Interest Notice 1 Jul 2026 5:52PM $0.180 $0.180 fallen by 0%
$108 Notification of cessation of securities - PAR 29 Jun 2026 5:01PM $0.165 $0.180 risen by 9.09%
$108 Notification of cessation of securities - PAR 29 Jun 2026 4:55PM $0.165 $0.180 risen by 9.09%
$108 Change of Director's Interest Notice 18 Jun 2026 5:46PM $0.180 $0.180 fallen by 0%
$108 Change of Director's Interest Notice 18 Jun 2026 5:46PM $0.180 $0.180 fallen by 0%
$108 Application for quotation of securities - PAR 18 Jun 2026 5:29PM $0.180 $0.180 fallen by 0%
$108 Listing of Options - Top 20 Holders and Distribution Reports 17 Jun 2026 10:52AM $0.160 $0.180 risen by 12.50%
$108 Application for quotation of securities - PAR 17 Jun 2026 10:50AM $0.160 $0.180 risen by 12.50%
$108 PAR Completes Enrolment in Pivotal Phase 3 15 Jun 2026 9:11AM $0.150 $0.180 risen by 20%
$108 Options Prospectus 11 Jun 2026 6:29PM $0.145 $0.180 risen by 24.14%
$108 Results of Meeting 11 Jun 2026 12:56PM $0.140 $0.180 risen by 28.57%
$108 Change of Director's Interest Notice 5 Jun 2026 6:34PM $0.145 $0.180 risen by 24.14%
$108 Change of Director's Interest Notice 5 Jun 2026 6:34PM $0.145 $0.180 risen by 24.14%
$108 Ceasing to be a substantial holder 4 Jun 2026 8:20AM $0.155 $0.180 risen by 16.13%
$108 Notification of cessation of securities - PAR 3 Jun 2026 5:34PM $0.155 $0.180 risen by 16.13%
$108 Application for quotation of securities - PAR 2 Jun 2026 5:31PM $0.155 $0.180 risen by 16.13%
$108 Application for quotation of securities - PAR 2 Jun 2026 10:18AM $0.158 $0.180 risen by 14.29%

1 - 25 of 720 results

Page 1 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.